Extension of replicative lifespan in WI-38 human fibroblasts by dexamethasone treatment is accompanied by suppression of p21 super(Waf1/Cip1/Sdi1) levels

Numerous studies have shown that supplementation of the growth medium of human fibroblasts with dexamethasone at physiologic concentrations extends replicative lifespan up to 30%. While this extension of lifespan has been used to probe various aspects of the senescent phenotype, no mechanism for the increased lifespan of human fibroblasts grown in the presence of dexamethasone has ever been identified. In the present study we present evidence that the extended lifespan of human lung fibroblasts (WI-38 cells) that occurs when these cells are maintained in culture medium supplemented with dexamethasone is accompanied by a suppression of p21 super(Waf1/Cip1/Sdi1) levels, which normally increase as these cells enter senescence, while p16 super(INK4a) levels are unaffected. These results suggest that the delay of senescence in cultures grown in the presence of dexamethasone is due to a suppression of the senescence related increase in p21 super(Waf1/Cip1/Sdi1). These results are consistent with models of replicative senescence in which p53 and p21 super(Waf1/Cip1/Sdi1) play a role in the establishment of the senescent arrest.